Keep up to date with what is going on at Deepbridge, our investee companies and other exciting news.

Glyconics Featured in Business Weekly
3rd July 2023
Glyconics, which is part of the Deepbridge Life Sciences EIS portfolio, has recently been featured in an article by Business Weekly regarding its…
Full article
SmallSpark Awarded New Contract From DASA
3rd July 2023
SmallSpark Space Systems, an award-winning rocket propulsion innovation company, which is part of the Deepbridge Technology Growth EIS fund, has…
Full article
Filisia Wins Accessible Education Award
26th June 2023
Filisia, an investee company within the Deepbridge Life Sciences EIS portfolio, has recently won the 'Accessible Education Award 2023' at the…
Full article
GenoMe Wins Best EIS Investee Company
26th June 2023
GenoME Diagnostics, an investee company within the Deepbridge Life Sciences EIS portfolio, has recently won the 'Best EIS Investee Company' award…
Full article
Deepbridge Joins Chester Raft Race
22nd June 2023
Deepbridge is due to set sail on the River Dee, Chester by entering into the annual Chester Raft Race, a 1/4 mile race on a homemade raft, from…
Full articleRecord year for EIS and SEIS
21st June 2023
HM Revenue & Customs (HMRC) recently released its latest Enterprise Investment Scheme (EIS) and Seed Enterprise Investment Scheme (SEIS) data for…
Full article
Deepbridge Shortlisted For Two EISA Awards
21st June 2023
Deepbridge Capital has been shortlisted for 2 awards at the upcoming 2023 EISA Awards, taking place at House of Lords on Thursday 22nd June. The …
Full articleCambridge United Partners with Mynurva
30th May 2023
Mynurva Limited, which is part of the Deepbridge Life Sciences EIS portfolio, has recently partnered with Cambridge United to offer round-the-clock…
Full articleSky Medical Technology’s Wearable Device Doubles Rate Of Wound Healing
17th May 2023
Sky Medical Technology Ltd, which is part of the Deepbridge Technology Growth EIS portfolio, has recently been featured in an article by Medical…
Full article
IbisVision Wins £4.5 Million In Growth Funding
16th May 2023
IbisVision, which is part of the Deepbridge Life Sciences EIS portfolio, has recently raised £4.5 million in growth funding as it seeks to open…
Full article
IbisVision Extends NHS Contract
28th April 2023
IbisVision, which is part of the Deepbridge Life Sciences EIS portfolio, has recently extended their contract with Forth Valley NHS while their…
Full article
Research reveals advisers prefer EIS to VCT
27th April 2023
Deepbridge have recently concluded an adviser survey that suggests financial advisers utilise the Enterprise Investment Scheme (EIS) investment…
Full article